Abstract
Introduction: While several authorized medicines and research drugs have displayed antiviral effectiveness against the SARS-CoV-2 , there are currently no validated antiviral therapies for treating gravely ill patients with COVID-19. No particular antiviral drug has been shown to be successful in treating patients with extreme coronavirus disease 2019 . Remdesivir (GS-5734), a nuclear analog drug, has inhibitory activity on pathogenic animals and coronaviruses in humans.Aim: The survey intented to evaluate the dental students ' awareness of Remdesivir therapy.Materials And Method: This was a cross-sectional type of research based on a questionnaire which included 100 dental college students in Chennai. A self-designed questionnaire with ten questions generating knowledge and awareness amongst dental college students about Remdesivir therapy. Questionnaires were distributed via an online database survey world. Questions discussed understanding of Remdesivir treatment, signs, counter-inications, action mechanism and side effects. Data were collected and analyzed after the answers were obtained from 100 participants.Results: 27% were aware about Remdesivir therapy . 15% were aware of the mechanism of action of Remdesivir therapy . 15% were aware of the indications of Remdesivir therapy . 12% were aware of the contraindications of Remdesivir therapy.14%.were aware of the side effects of Remdesivir therapy .Conclusion: There was limited awareness among dental students regarding Remdesivir in managing viral infections. Intensified awareness and education programmes must be instituted to disseminate knowledge about Remdesivir therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.